ELISA
Zeus Scientific Gets FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test
Late last year, the company received Emergency Use Authorization from the FDA for a test that detects IgG antibodies against SARS-CoV-2.
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Â
After nearly a year in development, the firm's rapid antigen test will be submitted by the end of March for a prescription-use claim.
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
Eurofins Gets CE Mark for Coronavirus Antibody Test
The company said that the test, which detects IgG antibodies against SARS-CoV-2, can be used to measure immune responses to the virus and vaccines.